Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25132 | BMS-986458 | 3005272-36-3 | 98% Min. |  |
| 25122 | Bisantrene HCl | 71439-68-4 | 98% Min. |  |
| Bisantrene, aslo known as CL-216942 and NSC 337766, is topoisomerase II poisons and D | ||||
| 25119 | BMS-986449 | 98% Min. |  | |
| BMS-986449 is a CELMoD molecular glue that redirects the E3 ubiquitin ligase Cereblon | ||||
| 25058 | BBC0403 | 2644662-83-7 | 98% Min. |  |
| BBC0403 is a selective BRD2 inhibitor. BBC0403 inhibits the progression of osteoarthr | ||||
| 25055 | BAY-593 free base | 2413020-56-9 | 98% Min. |  |
| BAY-593 is an orally active inhibitor of geranylgeranyltransferase-I (GGTase-I) that | ||||
| 25054 | Boscalid | 188425-85-6 | 98% Min. |  |
| Boscalid is a broad spectrum fungicide used in agriculture to protect crops from fung | ||||
| 25048 | BAY-1125976 | 1402608-02-9 | 98% Min. |  |
| BAY-1125976 is a potent and selective allosteric AKT1/2 inhibitor. BAY-1125976 exhibi | ||||
| 25032 | BMS-466442 | 1598424-76-0 | ≧98.0% |  |
| BMS-466442 is a small molecule inhibitor of asc-1. | ||||
| 24157 | BTA-EG4 hydrate | 921193-28-4 | 98% Min. |  |
| BTA-EG4 is a catalase-amyloid interaction inhibitor, which can significantly enhance | ||||
| 24117 | Bexicaserin | 2035818-24-5 | 98% Min. |  |
| Bexicaserin is a serotonin 5-HT2C receptor agonist. | ||||
| 24086 | BIIB-129 | 2770961-85-6 | 98% Min. |  |
| 24059 | 4-Bromoindole-3-carboxaldehyde | 98600-34-1 | 98% Min. |  |
| 24034 | Braco-19 trihydrochloride | 351351-75-2 | 98% Min. |  |
| Braco-19 is a potenttelomerase/telomereinhibitor, preventing the capping and catalyti | ||||
| 24025 | BIIB-129 | 2770960-52-4 | ≧98.0% |  |
| BIIB129 is a covalent, selective, small molecule inhibitor of Bruton's tyrosine k | ||||
| 20668 | BLU-451 | 2769954-39-2 | 98% Min. |  |
| BLU-451, also known as LNG-451, orally bioavailable, central nervous system (CNS) pen | ||||
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat is anorally available, irreversible inhibitor of lysine-specific demethyl | ||||
| 20620 | Brexpiprazole | 913611-97-9 | 98% Min. |  |
| Brexpiprazole, also known as OPC-34712, is a novel D2 dopamine partial agonist called | ||||
| 20619 | Berotralstat HCl | 1809010-52-3 | 98% Min. |  |
| Berotralstat HCl is a novel selective inhibitor of plasma kallikrein, blocking the en | ||||
| 20606 | Belzutifan | 1672668-24-4 | 98% Min. |  |
| Belzutifan, also known as PT2977 and MK-6482, is HIF-2alpha inhibitor. PT2977 binds t | ||||
| 20601 | BI-1467335 HCl | 1478364-68-9 | 98% Min. |  |
| BI-1467335, also known as PXS-4728A, is a SSAO/VAP inhibitor potentially for the trea | ||||
| 20599 | Bozitinib | 1440964-89-5 | 98% Min. |  |
| Bozitinib is a highly selective c-MET kinase inhibitor with blood-brain barrier perme | ||||
| 20597 | BMS-986176 | 1815613-42-3 | 98% Min. |  |
| BMS-986176, also known as LX9211, is a highly selective, CNS penetrant, potent AAK1 i | ||||
| 20570 | BBT | 445000-45-3 | 98% Min. |  |
| BBT is an enhancer of impaired glucose-stimulated insulin secretion (GSIS). | ||||
| 20554 | BML-278 | 120533-76-8 | 98% Min. |  |
| BML-278 is an activator of sirtuin 1 (SIRT1) that has an EC150 value (effective conce | ||||
| 20550 | BSJ-04-122 | 2513289-74-0 | 98% Min. |  |
| 20533 | brigimadlin | 2095116-40-6 | 98% Min. |  |
| Brigimadlin is an E3 ubiquitin-protein ligase Mdm2 inhibitor with potential as an ant | ||||
| 20519 | BMS-986120 | 1478712-37-6 | 98% Min. |  |
| BMS-986120 is a potent and selective oral antagonist of protease-activated receptor-4 | ||||
| 20518 | BMS-986141 | 1478711-48-6 | 98% Min. |  |
| BMS-986141 is an Orally-Active Small-Molecule Antagonist of the Platelet Protease-Act | ||||
| 20512 | BDTX-1535 | 2607829-38-7 | ≧98.0% |  |
| BDTX-1535 is a brain-penetrant and potent MasterKey inhibitor of oncogenic mutations | ||||
| 232252 | Brepocitinib Tosylate | 2140301-96-6 | ≧98.0% |  |
| Brepocitinib ( PF-06700841 ) is an orally available, selective inhibitor of non-recep | ||||